Concepedia

Edmond Chipumuro

EC

12

Publications

1.8K

Citations

12

H-Index

2008

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Whitehead Institute for Biomedical Research

Massachusetts Institute of Technology

Q Therapeutics (United States)

Edmond Chipumuro is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2008–2024

12

Publications

12

CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer

Edmond Chipumuro, Eugenio Marco, Camilla L. Christensen et al. · Cell · 2014 · 641 citations · Full text

, , +3

Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor

Camilla L. Christensen, Nicholas Kwiatkowski, Brian J. Abraham et al. · Cancer Cell · 2014 · 449 citations · Full text

, , +6

CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation

Małgorzata Krajewska, Ruben Dries, Andrew V. Grassetti et al. · Nature Communications · 2019 · 257 citations · Full text

Sequencing and analysis of the gene-rich space of cowpea

Michael P. Timko, Paul J. Rushton, Thomas W Laudeman et al. · BMC Genomics · 2008 · 116 citations · Full text

Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors

Yang Gao, Tinghu Zhang, Hideki Terai et al. · Cell chemical biology · 2017 · 76 citations · Full text

, , +5

Rows per page

1–5 of 12